Photo by The Washington Post
The senate has voted, and Robert Califf, a cardiologist and academic researcher most recently at Duke University, will be the next Food and Drug Administration commissioner. The vote, which was held last month, was 89 to 4.
“Dr. Califf is the right person with the right experience to build on the FDA’s unsurpassed record of protecting public health while encouraging innovation and the introduction of new life-saving therapies to the market,” Health and Human Services Secretary Sylvia M. Burwell said in a statement.
Califf joined the FDA one year ago and has been met with some opposition for his views, especially regarding the prescription painkiller epidemic to genetically engineered salmon.
“I think my record shows that I’m for medical products that work and are effective. When they’re not, I’ve been outspoken,” Califf told The Washington Post shortly after his confirmation. “I think the best testament is that I went through an amazingly rigorous committee, hundreds of pages of written documentation, and then a full senate review, and came out pretty well.”
Califf succeeds Margaret A. Hamburg, and he has received support from the American Heart Association, the Leukemia & Lymphoma Society and Friends of Cancer Research, according to The Washington Post.
For the full story, visit https://www.washingtonpost.com/news/to-your-health/wp/2016/02/24/senate-confirms-robert-califf-as-new-fda-commissioner/.
Robert Califf Named New FDA Commissioner
No comments:
Post a Comment